Evidence map›Paper›PMID 16280357›Full record

ArticleMolecular biology of the cell2006

Regulation of histone deacetylase 4 expression by the SP family of transcription factors.

Fang Liu, Nabendu Pore, Mijin Kim, K Ranh Voong, Melissa Dowling, Amit Maity, Gary D Kao

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fang LiuDepartment of Radiation Oncology, Philadelphia Veterans Affairs Medical Center, PA 19104, USA.
Nabendu Pore
Mijin Kim
K Ranh Voong
Melissa Dowling
Amit Maity
Gary D Kao
University of Pennsylvania · US

Funding

Regulation of VEGF in Tumors by Ras, EGF and PTENR01CA093638 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MAITY, AMIT · 2002 to 2010
$2.3M
HDAC4 Viability: Unique Mechanisms and FunctionR01CA107956 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KAO, GARY D · 2004 to 2007
$980k
NCI NIH HHS CA093638NCI NIH HHS CA107956NCI NIH HHS R01 CA093638NCI NIH HHS R01 CA107956
6 · The paper itself

Abstract

Histone deacetylases mediate critical cellular functions but relatively little is known about mechanisms controlling their expression, including expression of HDAC4, a class II HDAC implicated in the modulation of cellular differentiation and viability. Endogenous HDAC4 mRNA, protein levels and promoter activity were all readily repressed by mithramycin, suggesting regulation by GC-rich DNA sequences. We validated consensus binding sites for Sp1/Sp3 transcription factors in the HDAC4 promoter through truncation studies and targeted mutagenesis. Specific and functional binding by Sp1/Sp3 at these sites was confirmed with chromatin immunoprecipitation (ChIP) and electromobility shift assays (EMSA). Cotransfection of either Sp1 or Sp3 with a reporter driven by the HDAC4 promoter led to high activities in SL2 insect cells (which lack endogenous Sp1/Sp3). In human cells, restored expression of Sp1 and Sp3 up-regulated HDAC4 protein levels, whereas levels were decreased by RNA-interference-mediated knockdown of either protein. Finally, variable levels of Sp1 were in concordance with that of HDAC4 in a number of human tissues and cancer cell lines. These studies together characterize for the first time the activity of the HDAC4 promoter, through which Sp1 and Sp3 modulates expression of HDAC4 and which may contribute to tissue or cell-line-specific expression of HDAC4.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsBase SequenceBinding SitesCells, CulturedConsensus SequenceDrosophilaHeLa CellsHistone DeacetylasesHumansMaleMolecular Sequence DataPlicamycinPromoter Regions, GeneticRepressor ProteinsSp1 Transcription FactorHDAC4 protein, humanHistone DeacetylasesPlicamycinRepressor ProteinsSp1 Transcription FactorSp3 Transcription Factor

Identifiers

PMID16280357
PMCPMC1356571
OpenAlexW2167579556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.